chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a female with no known pertinent medical history and no known drug allergies who "about 2 weeks ago" (November 2007), was vaccinated with a single subcutaneous dose of ZOSTAVAX (Merck).  There was no concomitant medication.  It was indicated that "one day after vaccination" (date not reported), the patient developed redness and itching at the site of injection.  It was reported that the patient was examined in the physician's office and was improving without requiring therapy.  Laboratory and diagnostic studies were not performed.  A product quality complaint was not reported.  Additional information has been requested. Additional information is not expected.
Patient received 1st dose before 99 days; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient received 1st dose before 99 days) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient received 1st dose before 99 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient received 1st dose before 99 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided.  No treatment medications provided.
Staff member received TD Intrathecal to LFA with reaction of induration lasting about 1 week.
Pt presented with rash on upper chest and face - then continued to spread and itch, low grade fever of 100.3, and nausea/vomiting.  Pt was taking fluids well by the time she was seen in clinic, no current vesicles present at the time seen.
RED, MILD HOT/ INDURATED 4 X 5 CM AREA ON ANTERIOR LT. THIGH AT INJECTION SITE. TACTILE FEVER ON 09/13/2019 A.M RX- ORAL MOTRIN.;  SEEN TODAY AND RX 9/13/2019- TMP/SMX 7 ML P.O. BID X 7 DAYS ; DIPHENHYDRAMINE 2.5 ML Q6H PRN
Swollen, sore, hard, red, hot for 7 days following.  Used ice pack & ibuprofen.
Patient felt very sick and weak after getting both Shingrix and Prevnar 20 together. Went to ER and was diagnosed with A-fib. Is not on medication to treat A-fib.
second shot my symptoms were worst fever 103 sever chills and horrible sweats, all my joint hurts, had nausea and my headache; second shot my symptoms were worst fever 103 sever chills and horrible sweats, all my joint hurts, had nausea and my headache; second shot my symptoms were worst fever 103 sever chills and horrible sweats, all my joint hurts, had nausea and my headache; second shot my symptoms were worst fever 103 sever chills and horrible sweats, all my joint hurts, had nausea and my headache; second shot my symptoms were worst fever 103 sever chills and horrible sweats, all my joint hurts, had nausea and my headache; second shot my symptoms were worst fever 103 sever chills and horrible sweats, all my joint hurts, had nausea and my headache; my appetite hasn't returned; my symptoms were worst; This is a spontaneous report from a contactable consumer (patient). A 49-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6205), via an unspecified route on 12Mar2021 (at the age of 49-years) as dose 2, single in the left arm for covid-19 immunisation. The patient medical history was not reported. The patient had no known allergies. The patient concomitant medications included Vitamin D, Vitamin c, Vitamin B12 from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL9266), via an unspecified route on 20Feb2021 at 12:00 (at the age of 49-years) as dose 1, single in the left arm for covid-19 immunisation and experienced flu symptoms fever of 101 chills body aches for 12 hours. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Mar2021at 22:00, the patient experienced after second shot her symptoms were worst fever 103 sever chills and horrible sweats, all her joint hurts, had nausea and her headache was so severe for 36 hours and her headache was the one that's lingering and her appetite had not returned. Patient did not received treatment for events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Light headed/ dizzy; Racing heart; Body pain; Severe metal taste in mouth; Tired for a week.; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 17Mar2021 at 11:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient had medical history of known allergies to penicillin (MANUFACTURER UNKNOWN). The patient received codeine (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced drug allergy. Concomitant medications included vitamin d nos (VITAMIN D), estradiol (MANUFACTURER UNKNOWN) and duloxetine hydrochloride (CYMBALTA); all from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Mar2021 at 11:00, the patient experienced light headed, dizzy, racing heart, body pain, severe metal taste in mouth that still wouldn't go away and tired for a week. No therapeutic measures were taken for the reported events. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event tired for a week was recovered on 24Mar2021, while the clinical outcome of the events light headed, dizzy, racing heart, body pain and severe metal taste were not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
I developed severe lower back/flank pain about 4 days after receiving my 2nd Moderna vaccination.  The pain was most pronounced while lying supine and , while in that position, manifested a creeping , fluid nature, i.e. migrating from my lower back to my shoulder.  I was unable to lie down comfortably.  In thinking about the nature of this pain, I determined that it was possibly/probably from a PE as it seemed as if  pain was migrating from my lower back to my shoulder.  I'm "not a doctor but play one on TV" (LOL ) so surmised that it was something serious that  decided that this was something needing attention.  I presented to a hospital ER for care and was ultimately told I had 2 small PE blood clots - 1 in the base of each lung.  My diagnosis was confirmed by a CT scan and I was subsequently admitted for observation.  I was discharged the following day with blood thinners and blood pressure medication.
Approximately one hour after the vaccination, a fine red rash with itching developed.  The rash spread from the abdomen to the left side of face and under the left eye.  Benadryl given and now only has a small red spot on the abdomen.
I received a pneumococcal shot in AM of 1/24/2018. My arm swelled up, was very red and warm all the way from my upper arm where shot was given to my wrist. I waited a day and the swelling and redness did not go away. I went to urgent care and the Dr. there said "Oh my". She prescribed an antibiotic. She didn't seem to know what it was, an infection or something else.
Vaccine #2 administered on Saturday, in addition to the normal side effects that started about 6 hours later, woke  up Sunday morning and right eye was nearly swollen shut. Then woke up Monday morning and large facial swelling of left cheek/lip/jaw. By noontime on Monday small amount of swelling began on upper right lip.  Benadryl was taken at that time. No change to amount of swelling at either site but did not continue to get bigger.  Spoke with dentist who advised contacting PCP. Left message for PCP.  Benadryl repeated at bedtime on Monday.  Tuesday morning eye was completely back to normal, only very minimal right lip swelling and still moderate left jaw/cheek swelling, though appears to be resolving.  Post nasal drip causing cough but no respiratory distress or trouble swallowing at any point.  PCP called back on Tuesday and wanted to see me.  Diagnoses as Allergic reaction to vaccine, no need for steroid or epinephrine, but advised to take antihistamine for another 3-4 days and not to receive booster dose of Moderna in the future, should they be recommended and have Benadryl on hand if receive booster of different manufacturer.
Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Tingling (specify: facial area, extremities)-Severe, Additional Details: tingling on the right side and front of face to the right temple had tingling, numbness, a bruised like feeling. PCP reviewed patients symptoms and stated everything was ok.
No initial adverse reaction to vaccine and negligible localized pain at injection site.  Sudden onset chills, severe tremors, and muscle spasm beginning +12h after vaccine administration, lasting ~2 hours followed by high fever (peak 103.6F), treated with acetaminophen OTC.  Persistent fever (>100F) until +18h after vaccine administration.  Fatigue, headache, muscle soreness persisting +24h after administration.
pt came in for immun w/in 5 mins p/vax wheal appeared near inject site; No other sx pt has given DPH; redness & wheal reduced
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (11 Doses administered after 30-day Use By Date) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination. No Medical History information was reported. On 05-Jan-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (11 Doses administered after 30-day Use By Date). On 05-Jan-2022, EXPIRED PRODUCT ADMINISTERED (11 Doses administered after 30-day Use By Date) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was provided. No treatment medications was provided. HCP is an LPN who reports they had some Moderna vaccine put out of the freezer on 01Dec2021and placed in the refrigerator, so it was not supposed to be used beyond 31Dec2021 but 11 doses were administered on 05Jan2022.
One week after receiving my first vaccination dose, I experienced itching and a large red lump at the exact site of the injection in my upper left arm.
claims they had a Prevnar 13 reaction that was/at the placement/administration site; Symptoms included pain, swelling, etc. at the placement/administration site.; Symptoms included pain, swelling, etc. at the placement/administration site.; This is a Spontaneous report based on the information received from a contactable consumer by Pfizer.  A patient of unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, Lot # X91013) via an unspecified route of administration at single dose on an unspecified date for immunisatio.   The patient medical history and concomitant medications were not reported.  The patient experienced PREVNAR 13 reaction and symptoms included as pain, swelling, etc. at the placement/administration site on 26Jun2019. The outcome of the events was unknown.
Facial numbness, throat sore, shortness of breath, difficulty breathing, difficulty swallowing started approx. 15 mins after receiving injection. Client went to Hospital Emergency room, was treated with BENADRYL, DECADRON and updraft treatment.
H1N1 FLUMIST was administered to a 53 year old. Vaccine error.
3 hours after started feeling tired, went to bed early. Next morning - Sore arm up into shoulder and neck, lasted a week Whole-body muscle ache, headache, nausea, diarrhea, exhaustion, lasted two days. The shot was given on a Thursday and had to miss work the next day.
Two days post vaccination large knot, discolorations and swelling occurred.  Knot was about 2.5" in diameter with the center being a dark black color that was about 1.5" in diameter.  The outside of the diameter was a bright red color, looked kinda like cellulitis.  Area was warm to the touch.  Treated it by placing ice pack on leg for 15 minutes over the course of eight hours.  The next day the area was less red and the black center was slowly going away.  By the third day the site had decreased significantly and the fourth it was pretty much gone.
Friend died 2 days after receiving the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DEATH (Friend died 2 days after receiving the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed.            Treatment information not provided. Concomitant medications were reported as statins and blood pressure medication.  This a report of dead, two days after Moderna COVID-19  vaccination  in a  patient of an unknown age and gender. Autopsy was not performed. Very limited information regarding the event has been provided for inferring causality. Further information is not expected; Sender's Comments: This a report of dead, two days after Moderna COVID-19  vaccination  in a  patient of an unknown age and gender. Autopsy was not performed. Very limited information regarding the event has been provided for inferring causality. Further information is not expected; Reported Cause(s) of Death: unknown cause of death.
Patient developed a varicelliform rash on medial elbow, in the same location as shingles a year ago, along with stiffness, pain in the left arm, 6 days following vaccination for COVID 19 with Moderna.
Vaccine was expired on 24-Mar-2022 and was stored in refrigeration on 29-Mar-2022 and administered on 26-APR-2022; Adminstered vaccine past the expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Adminstered vaccine past the expiration date) and PRODUCT STORAGE ERROR (Vaccine was expired on 24-Mar-2022 and was stored in refrigeration on 29-Mar-2022 and administered on 26-APR-2022) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 022J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Adminstered vaccine past the expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 24-Mar-2022 and was stored in refrigeration on 29-Mar-2022 and administered on 26-APR-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Adminstered vaccine past the expiration date) and PRODUCT STORAGE ERROR (Vaccine was expired on 24-Mar-2022 and was stored in refrigeration on 29-Mar-2022 and administered on 26-APR-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter.  Reportedly, by used date was mentioned as 24-Apr-2022. The vaccines were stored in the freezer and only removed as needed to thaw and then administered. It was mentioned that vials were taken out at a time and thawed as they did not thawed an entire box.  Treatment details were not reported by the reporter.
pt reports headache started the evening after vaccination. also with nausea and vomiting x 5 hours on the morning of 7/29/22, then resolved. HA now intermittent.
vaccine expired on 08/31/2021 and vaccine was administered on 09/07/2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine expired on 08/31/2021 and vaccine was administered on 09/07/2021) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.    On 07-Sep-2021 at 2:47 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine expired on 08/31/2021 and vaccine was administered on 09/07/2021). On 07-Sep-2021, EXPIRED PRODUCT ADMINISTERED (vaccine expired on 08/31/2021 and vaccine was administered on 09/07/2021) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment drugs were reported.  It was reported that patient had not tested positive for COVID-19.
pruritus of ears and hoarseness/loss of voice 30 minutes after vaccine administration. Given 25mg of Benadryl and 40mg of prednisone. Continues to have loss of voice despite treatment with antihistamine and oral prednisone.
My arm warm at the injection site.; I feel nauseous; My arm is red at the injection site.; Received vaccine while pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (My arm warm at the injection site.), MATERNAL EXPOSURE DURING PREGNANCY (Received vaccine while pregnant), NAUSEA (I feel nauseous) and VACCINATION SITE ERYTHEMA (My arm is red at the injection site.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 28-May-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Received vaccine while pregnant). On an unknown date, the patient experienced VACCINATION SITE WARMTH (My arm warm at the injection site.), NAUSEA (I feel nauseous) and VACCINATION SITE ERYTHEMA (My arm is red at the injection site.). On 28-May-2021, MATERNAL EXPOSURE DURING PREGNANCY (Received vaccine while pregnant) had resolved. At the time of the report, VACCINATION SITE WARMTH (My arm warm at the injection site.), NAUSEA (I feel nauseous) and VACCINATION SITE ERYTHEMA (My arm is red at the injection site.) outcome was unknown.            No concomitant medications were reported. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: Internal review on 22-Jul-2021 resulted in update to pregnancy information and second dose date.
This spontaneous report as received from a pharmacist refers to a 56 year old female patient. In May 2013 (reported as last week, exact date unspecified), the patient was vaccinated with ZOSTAVAX in the arm (dose, route and lot # not reported). The pharmacist reported that the patient (anonymous) developed a rash under her arm at the injection site. On an unspecified date, the patient recovered from rash under her arm at the injection site. Additional information is not expected.
Left leg swelling thigh to knee, with warm to touch, slightly red. Tx -> TYLENOL OTC and BENADRYL. Return 1 wk if not improve.
HIVES TO LOWER BACK EXTENDING TO RIGHT LOWER ABDOMEN. BENADRYL. RESOLVED BY MORNING
Nurse made an dilution error by mixing 0.6ml with pfizer 30mcg/0.3ml vial. Then she administered 0.3ml from the vial and administered the vaccine to the patient.
About 5 minutes following administration of the vaccine, patient was walking and fainted. Quickly came to after lying down, taking soda and crackers.
This is a spontaneous report from a contactable nurse received via a Pfizer sales representative. An adolescent female patient started to receive TRUMENBA on 08Mar2019 and MENACTRA on an unspecified date, both via an unspecified route of administration at a single dose for an immunization. Medical history was none. The patient's concomitant medications were not reported. On 08Mar2019, the reporter stated that the patient experienced dizziness after taking meningococcal group brlp2086. The patient was on day 4 of dizziness. The outcome of the event was not recovered.
Pt felt cold and clammy after the Covid vaccination for about 2 min. We took care of him.We were with him all the time and was checking on him. He was with us until he was doing great.
Extreme fatigue, body aches, and headaches that began around day 4 post vaccine.; Extreme fatigue, body aches, and headaches that began around day 4 post vaccine.; Extreme fatigue, body aches, and headaches that began around day 4 post vaccine.; This is a spontaneous report from a contactable Other HCP reporting for herself. A 50-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EK5730), Intramuscular on 22Dec2020 17:45 at single dose for covid-19 immunisation. Vaccine administered in left arm. Medical history included Anemia and Hypothyroidism. Patient is not pregnant. Concomitant medication was not reported. Patient had allergies to Levaquin. The patient experienced extreme fatigue, body aches, and headaches that began around day 4 post vaccine on 26Dec2020. Patient has not been tested for coronavirus disease (COVID-19). Patient was not diagnosed with COVID-19. Outcome of events was not recovered.
Started having headaches about 2 weeks out from first shot, 18 days exactly seizures started and had not had a seizure in over 5-6 years. I have had 3 partial complex seizures since the 18th. I was advised to hold off on second dose until recieved new seizure meds and had them in my system for 4-5 days at least.. I have started taking topiramate now due to seizures. I do not think I will get second dose due to neuro risk.
Came down with COVID the night he got his first dose; This spontaneous case was reported by a health care professional and describes the occurrence of COVID-19 (Came down with COVID the night he got his first dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced COVID-19 (Came down with COVID the night he got his first dose). At the time of the report, COVID-19 (Came down with COVID the night he got his first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Treatment medications were not provided.